Article: ID Biomedical Corp.: Senior Vaccine Development Scientist, Dr. Mark Reddish, Joins ID Biomedical Subsidiary.

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jan. 14, 1998--ID BIOMED. (TSE:IDB.) (NASDAQ:IDBEF) ID Biomedical Corporation announced today that Dr. Mark Reddish, Ph.D. has been appointed Vice President, Product Development of its subsidiary company, ID Vaccine Corporation, based in Seattle, WA.

Dr. Reddish will join the team of industry specialists that is being assembled by ID Vaccine to advance the development of its vaccine products.

Todd Patrick, President of ID Vaccine, said , "Dr. Reddish will add considerable industry experience and expertise to ID Vaccine's product development team as we prepare for human testing of our group A ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!